Search results
The Gilead Sciences Inc (GILD) Company: A Short SWOT Analysis
GuruFocus.com via Yahoo Finance· 6 months agoRobust product sales growth, with a focus on infectious diseases, cardiovascular diseases, and...
Gilead Sciences, Inc. (NASDAQ:GILD) Q4 2023 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 months agoGilead Sciences, Inc. (NASDAQ:GILD) Q4 2023 Earnings Call Transcript February 6, 2024 Gilead...
Gilead Foundation Awards $20 Million to Organizations Working to Advance Health Through Education...
ACCESSWIRE via Yahoo Finance· 2 years agoGilead Sciences, Inc. (Nasdaq:GILD) recently announced that the Gilead Foundation's Creating...
Zacks Industry Outlook Highlights Gilead Sciences, CRISPR Therapeutics, ACADIA Pharmaceuticals,...
Zacks via Yahoo Finance· 6 months agoFor Immediate Release Chicago, IL – November 24, 2023 – Today, Zacks Equity Research discusses...
Q1 2024 Gilead Sciences Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 weeks agoParticipants Andrew D. Dickinson; CFO; Gilead Sciences, Inc. Cindy Perettie; EVP of Kite; Gilead Sciences, Inc. Daniel P. O'Day; Chairman & CEO; Gilead Sciences, Inc. Jacquie Ross; VP of IR; ...
Gilead's Biktarvy Demonstrates High Efficacy In HIV/HBV Coinfection Patients
Benzinga via Yahoo Finance· 2 years agoGilead Sciences Inc (NASDAQ: GILD) announced results reinforcing Biktarvy...
Gilead Sciences (GILD) Q3 Earnings and Revenues Top Estimates
Zacks via Yahoo Finance· 2 years agoGilead (GILD) delivered earnings and revenue surprises of 31.94% and 15.06%, respectively, for the...
Gilead's (GILD) Veklury Gets Positive CHMP View for Extended Use
Zacks via Yahoo Finance· 12 months agoGilead (GILD) obtains positive opinion for the use of Veklury in COVID-19 patients with severe renal...
Zacks Industry Outlook Highlights Gilead Sciences, GSK, Immunocore and Syndax Pharmaceuticals
Zacks via Yahoo Finance· 1 year agoFor Immediate Release Chicago, IL – December 28, 2022 – Today, Zacks Equity Research discusses...
Biotech Stock Roundup: CGEN Up on GILD Deal, MRNA Gains on Study Data & More
Zacks via Yahoo Finance· 5 months agoIt has been a busy week for the biotech sector, with a lot of updates on collaborations, study...